| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0002-9343(97)00346-X |
| P8608 | Fatcat ID | release_gzhtbryh5rfepie6i2kb5m3hcq |
| P698 | PubMed publication ID | 9552091 |
| P2093 | author name string | DiMarco JP | |
| Jung F | |||
| P2860 | cites work | Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter | Q72352921 |
| Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation | Q72360980 | ||
| Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation | Q72468018 | ||
| Radiofrequency catheter ablation and modulation of atrioventricular conduction in patients with atrial fibrillation | Q72520812 | ||
| Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation | Q72526986 | ||
| Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation | Q72655008 | ||
| Long-term Prevention of Vagal Atrial Arrhythmias by Atrial Pacing at 90/Minute: Experience with 6 Cases | Q72703031 | ||
| Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation | Q72708430 | ||
| Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease | Q72906519 | ||
| Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter | Q72906522 | ||
| A focal source of atrial fibrillation treated by discrete radiofrequency ablation | Q73047603 | ||
| Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography | Q73055216 | ||
| Initial clinical experience with an implantable human atrial defibrillator | Q73275601 | ||
| Frequency-dependent effects of verapamil on atrioventricular nodal conduction in man | Q93570963 | ||
| Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response | Q93632895 | ||
| Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms | Q93874542 | ||
| The effect of amiodarone, a new anti-anginal drug, on cardiac muscle | Q24669966 | ||
| Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial | Q28300531 | ||
| Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators | Q28318466 | ||
| Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs | Q28329458 | ||
| Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation | Q28340885 | ||
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| Symptoms, Cardiovascular Risk Profile and Spontaneous ECG in Paced Patients: A Five-Year Follow-Up Study | Q33154377 | ||
| Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide | Q33169834 | ||
| Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators | Q33978001 | ||
| Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion | Q34272548 | ||
| Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome | Q34327153 | ||
| Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity | Q34345947 | ||
| Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats | Q34721297 | ||
| Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study | Q34727157 | ||
| Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study | Q34734292 | ||
| Low-dose amiodarone for atrial fibrillation: time for a prospective study? | Q36110401 | ||
| Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing | Q36147790 | ||
| Proarrhythmia in patients treated for atrial fibrillation or flutter | Q36212688 | ||
| Cardioversion of atrial fibrillation of recent onset with flecainide | Q36682078 | ||
| Sotalol for paroxysmal supraventricular tachycardias | Q38137740 | ||
| Summary of efficacy and safety of flecainide for supraventricular arrhythmias | Q39604703 | ||
| Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutter | Q40694749 | ||
| Comparative mechanisms of action of antiarrhythmic drugs | Q40779069 | ||
| Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients | Q40795044 | ||
| Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy | Q41179390 | ||
| Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy | Q42229679 | ||
| Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome | Q42260182 | ||
| Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the sotalol-digoxin-quinidine trial) | Q42277566 | ||
| Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group | Q42281464 | ||
| Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group | Q42284109 | ||
| Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil | Q43453208 | ||
| Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators | Q43764537 | ||
| Canadian atrial fibrillation anticoaguiation (CAFA) study | Q43928649 | ||
| Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial | Q43969736 | ||
| Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter | Q44145766 | ||
| The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation | Q44153210 | ||
| Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy | Q44432066 | ||
| Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset | Q44526252 | ||
| Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing | Q71112035 | ||
| Response of atrial fibrillation to therapy: role of etiology and left atrial diameter | Q71161676 | ||
| Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing | Q71442256 | ||
| Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias | Q71561359 | ||
| Clinical course of acute atrial fibrillation treated with rapid digitalization | Q71657363 | ||
| Coronary heart disease and atrial fibrillation: the Framingham Study | Q71782665 | ||
| Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure | Q71964525 | ||
| Effects of Verapamil on Electrophysiological Properties in Paroxysmal Atrial Fibrillation | Q72072516 | ||
| Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter | Q72226782 | ||
| ??? | Q28341602 | ||
| A prospective randomized comparison of direct current and radiofrequency ablation of the atrioventricular junction | Q44635054 | ||
| Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction | Q44843427 | ||
| Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. | Q45985183 | ||
| Influence of cardiac pacing mode on the long-term development of atrial fibrillation | Q46112641 | ||
| Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation | Q46213915 | ||
| Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation | Q46248979 | ||
| Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction | Q46265465 | ||
| Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter | Q46919157 | ||
| Embolic stroke after unanticoagulated cardioversion despite prior exclusion of atrial thrombi by transoesophageal echocardiography | Q49167948 | ||
| Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. | Q51604516 | ||
| Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. | Q52342463 | ||
| A new pacing algorithm for overdrive suppression of atrial fibrillation. Chorus Multicentre Study Group. | Q52367542 | ||
| Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. | Q53616919 | ||
| Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. | Q54087868 | ||
| Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis--a randomised cross-over study. | Q54103002 | ||
| Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. | Q54114563 | ||
| Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. | Q54126951 | ||
| Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. | Q55054117 | ||
| Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial | Q56659254 | ||
| Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation | Q57786465 | ||
| Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension | Q58819310 | ||
| Chronotropic response to exercise in patients with atrial fibrillation | Q67654740 | ||
| Morbidity and Mortality of Patients with Sinus Node Disease: Comparative Effects of Atrial and Ventricular Pacing | Q67681591 | ||
| Differences Between Atrial Single Chamber Pacing (AAI) and Ventricular Single Chamber Pacing (VVI) with Respect to Prognosis and Antiarrhythmic Effect in Patients with Sick Sinus Syndrome | Q67681594 | ||
| Stroke Prevention in Atrial Fibrillation Study. Final results | Q67925848 | ||
| Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation | Q67969056 | ||
| Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias | Q67986525 | ||
| Efficacy of flecainide for the reversion of acute onset atrial fibrillation | Q68025039 | ||
| Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group | Q68058122 | ||
| Management of atrial fibrillation | Q68092512 | ||
| The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm | Q68368848 | ||
| Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality | Q68444637 | ||
| Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation | Q68498046 | ||
| Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation | Q68516428 | ||
| Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs | Q68709077 | ||
| Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm | Q68899284 | ||
| Effects of amiodarone and desethylamiodarone on rabbit myocardial beta-adrenoceptors and serum thyroid hormones--absence of relationship to serum and myocardial drug concentrations | Q68974724 | ||
| Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity | Q69122924 | ||
| Improved control of atrial fibrillation with combined pindolol and digoxin therapy | Q69580054 | ||
| Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus | Q69990661 | ||
| Epidemiologic features of chronic atrial fibrillation: the Framingham study | Q70294399 | ||
| Comparison of flecainide and procainamide in cardioversion of atrial fibrillation | Q70493406 | ||
| Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation | Q70523605 | ||
| Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation | Q70573988 | ||
| Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone | Q70579175 | ||
| Internal cardioversion of atrial fibrillation in sheep | Q70709381 | ||
| Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation | Q70906358 | ||
| Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study | Q71020117 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P304 | page(s) | 272-286 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Treatment strategies for atrial fibrillation | |
| P478 | volume | 104 |
| Q53347408 | Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. |
| Q30312187 | Antiarrhythmic drug therapy of atrial fibrillation |
| Q34114443 | Antidysrhythmics. Emergent |
| Q33900087 | Appropriate outcome measures in trials evaluating treatment of atrial fibrillation |
| Q34126043 | Atrial fibrillation: current and future strategies for management |
| Q49194056 | Cardioversion in the third trimester of pregnancy |
| Q44147865 | Cardioversion of atrial fibrillation with ibutilide: when is it most effective? |
| Q35877363 | Cost effectiveness of therapies for atrial fibrillation. A review |
| Q43926578 | Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial |
| Q35168643 | Emergency management of atrial fibrillation |
| Q35114522 | Evolution of non-pharmacological curative therapy for atrial fibrillation. Where do we stand today? |
| Q43542507 | Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle |
| Q37666451 | Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial |
| Q73699021 | Matrix metalloproteinases and atrial structural remodeling |
| Q34778146 | Mechanisms of antiarrhythmic drug actions and their clinical relevance for controlling disorders of cardiac rhythm |
| Q47918768 | Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation |
| Q52046782 | Optimal ventricular rate slowing during atrial fibrillation by feedback AV nodal-selective vagal stimulation. |
| Q37226141 | Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response. |
| Q35984267 | Pulmonary vein ablation of atrial fibrillation: beyond the traditional. |
| Q78287671 | Remodeling of the left atrium in pacing-induced atrial cardiomyopathy |
| Q24804548 | Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation |
| Q53886006 | Selective AV nodal vagal stimulation improves hemodynamics during acute atrial fibrillation in dogs. |
| Q33861831 | The tachycardia-induced dog model of atrial fibrillation. clinical relevance and comparison with other models |
| Q44018482 | Therapeutic effects of selective atrioventricular node vagal stimulation in atrial fibrillation and heart failure |
| Q79123512 | Transvenous Electrical Cardioversion in Equine Atrial Fibrillation: Technique and Successful Treatment of 3 Horses |
| Q81729175 | [Controversies in auricular fibrillation: does sinus rhythm have to be maintained?] |
| Q74622550 | [New concepts on the treatment of atrial fibrillation] |
| Q73656203 | [Practice guidelines of the Spanish Society of Cardiology on cardiac arrythmias] |
Search more.